Aralez Pharmaceuticals Overview
- Year Founded
-
1996
- Status
-
Private
- Employees
-
164
- Latest Deal Type
-
Bankr. Admin/Reorg
Aralez Pharmaceuticals General Information
Description
Old API Wind-down Ltd, formerly Aralez Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in the acquisition, development, and commercialization of products primarily in cardiovascular, pain management and other specialty areas. Its key products include Fiorinal, Proferrin, Fibricor, Uracyst and Neovisc, Cambia and other marketed products. The company currently operates in two geographical markets, the United States and Canada. The firm generates most of its revenue from the United States.
Contact Information
Website
www.aralez.comCorporate Office
- PO Box 329003
- Brooklyn, NY 11232
- United States
Corporate Office
- PO Box 329003
- Brooklyn, NY 11232
- United States
Aralez Pharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 9. Bankruptcy: Admin/Reorg | 10-Aug-2018 | Completed | Bankruptcy: Admin/Reorg | |||
| 8. PIPE | 05-Feb-2016 | Completed | Generating Revenue | |||
| 7. IPO | 11-Oct-2000 | Completed | Generating Revenue | |||
| 6. Later Stage VC (Series F) | 28-Aug-2000 | Completed | Generating Revenue | |||
| 5. Later Stage VC (Series E) | 24-Mar-2000 | Completed | Generating Revenue | |||
| 4. Later Stage VC (Series D) | 01-Sep-1999 | Completed | Generating Revenue | |||
| 3. Later Stage VC (Series C) | 01-Mar-1998 | Completed | Generating Revenue | |||
| 2. Early Stage VC (Series B) | 01-Mar-1998 | $4.56M | $11.2M | Completed | Generating Revenue | |
| 1. Early Stage VC (Series A) | 01-Dec-1996 | $6.63M | $6.63M | Completed | Product Development |
Aralez Pharmaceuticals Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series F | ||||||||
| Series E | ||||||||
| Series D | ||||||||
| Series C | ||||||||
| Series B | 4,000,000 | $0.001000 | $4 | $4 | 1x | $4 | 6.92% | |
| Series A | 2,750,000 | $0.001000 | $3.15 | $3.15 | 1x | $3.15 | 12.79% |
Aralez Pharmaceuticals Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Aralez Pharmaceuticals Patents
Aralez Pharmaceuticals Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-2797600-A2 | Improved compositions and methods for delivery of omeprazole plus acetylsalicylic acid | Inactive | 28-Dec-2011 | ||
| EP-2797600-A4 | Improved compositions and methods for delivery of omeprazole plus acetylsalicylic acid | Inactive | 28-Dec-2011 | ||
| CA-2848764-A1 | Controlled dosing of clopidogrel with gastric acid inhibition therapies | Inactive | 14-Sep-2011 | ||
| EP-2755641-A1 | Controlled dosing of clopidogrel with gastric acid inhibition therapies | Inactive | 14-Sep-2011 | ||
| EP-2755641-A4 | Controlled dosing of clopidogrel with gastric acid inhibition therapies | Inactive | 14-Sep-2011 | A61K31/4365 |
Aralez Pharmaceuticals Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Aralez Pharmaceuticals Investments & Acquisitions (2)
Aralez Pharmaceuticals’s most recent deal was a Corporate Asset Purchase with Deerfield Management (US Rights for Toprol-XL) for . The deal was made on 04-Oct-2016.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Deerfield Management (US Rights for Toprol-XL) | 04-Oct-2016 | Corporate Asset Purchase | Buildings and Property | ||
| Tribute Pharmaceuticals | 05-Feb-2016 | Merger/Acquisition | Pharmaceuticals |
Aralez Pharmaceuticals ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Pharmaceuticals
Industry
Rank
Percentile
Pharmaceuticals
Subindustry
Rank
Percentile
Aralez Pharmaceuticals FAQs
-
When was Aralez Pharmaceuticals founded?
Aralez Pharmaceuticals was founded in 1996.
-
Where is Aralez Pharmaceuticals headquartered?
Aralez Pharmaceuticals is headquartered in Brooklyn, NY.
-
What is the size of Aralez Pharmaceuticals?
Aralez Pharmaceuticals has 164 total employees.
-
What industry is Aralez Pharmaceuticals in?
Aralez Pharmaceuticals’s primary industry is Pharmaceuticals.
-
Is Aralez Pharmaceuticals a private or public company?
Aralez Pharmaceuticals is a Private company.
-
What is Aralez Pharmaceuticals’s current revenue?
The current revenue for Aralez Pharmaceuticals is .
-
How much funding has Aralez Pharmaceuticals raised over time?
Aralez Pharmaceuticals has raised $405M.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
